Young Suk Park Selected Research

Precision Medicine

8/2023	Tumor mutation burden in gastro-entero-pancreatic-neuroendocrine neoplasms.
1/2018	Antitumor activity of sorafenib plus CDK4/6 inhibitor in pancreatic patient derived cell with KRAS mutation.
10/2017	Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients and Utility for Biomarker-Selected Clinical Trials.
1/2016	Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era.
10/2011	Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy.
6/2011	Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young Suk Park Research Topics

Disease

131	Neoplasms (Cancer) 12/2023 - 10/2004
90	Stomach Neoplasms (Stomach Cancer) 12/2023 - 12/2005
56	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2004
27	Rectal Neoplasms (Rectal Cancer) 01/2023 - 07/2010
24	Neoplasm Metastasis (Metastasis) 12/2023 - 10/2003
21	Adenocarcinoma 03/2021 - 01/2004
18	Disease Progression 09/2023 - 01/2006
17	Biliary Tract Neoplasms (Biliary Tract Cancer) 09/2023 - 03/2006
17	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 04/2007
12	Colonic Neoplasms (Colon Cancer) 11/2022 - 04/2007
10	Obesity 12/2023 - 06/2016
8	Anemia 01/2020 - 01/2006
7	Microsatellite Instability 08/2023 - 09/2010
7	Diarrhea 01/2018 - 01/2004
6	Hemorrhage 02/2023 - 12/2009
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
6	Nausea 05/2017 - 06/2002
5	Morbid Obesity 01/2023 - 12/2017
5	Weight Loss (Weight Reduction) 12/2022 - 10/2017
5	Neutropenia 04/2019 - 11/2004
5	Ascites 01/2018 - 01/2011
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 06/2003
5	Hepatocellular Carcinoma (Hepatoma) 08/2012 - 11/2004
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2023 - 12/2012
4	Fatigue 01/2018 - 03/2011
4	Carcinoma (Carcinomatosis) 09/2015 - 10/2003
4	Vomiting 06/2015 - 06/2002
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021 - 06/2015
3	Lymphatic Metastasis 12/2017 - 09/2014
3	Carcinogenesis 11/2017 - 08/2009
3	Hand-Foot Syndrome 05/2017 - 08/2007
3	Abdominal Pain (Pain, Abdominal) 10/2015 - 03/2011
3	Thrombocytopenia (Thrombopenia) 10/2014 - 11/2004
3	Anorexia 05/2012 - 08/2007
2	Wounds and Injuries (Trauma) 03/2024 - 12/2023

Drug/Important Bio-Agent (IBA)

37	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2023 - 07/2005
34	Capecitabine (Xeloda)FDA Link 01/2023 - 01/2004
24	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 04/2005
24	Irinotecan (Camptosar)FDA LinkGeneric 03/2023 - 01/2004
21	Gemcitabine FDA Link 09/2023 - 03/2006
21	Biomarkers (Surrogate Marker)IBA 08/2023 - 08/2009
18	Cisplatin (Platino)FDA LinkGeneric 09/2023 - 06/2003
18	Leucovorin (Folinic Acid)FDA Link 03/2023 - 04/2005
16	Proteins (Proteins, Gene)FDA Link 04/2023 - 10/2003
14	Bevacizumab (Avastin)FDA Link 03/2023 - 02/2013
11	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2023 - 04/2007
10	Cetuximab (Erbitux)FDA Link 12/2023 - 04/2011
8	ParaffinIBA 12/2023 - 01/2004
8	Simvastatin (Zocor)FDA LinkGeneric 01/2023 - 09/2009
7	XELOXIBA 07/2019 - 04/2011
7	Everolimus FDA Link 01/2019 - 07/2011
6	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 10/2002
6	Docetaxel (Taxotere)FDA Link 04/2019 - 01/2007
6	Monoclonal AntibodiesIBA 01/2019 - 09/2015
6	Phosphotransferases (Kinase)IBA 11/2015 - 04/2007
5	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2006
5	B7-H1 AntigenIBA 01/2023 - 01/2016
5	Paclitaxel (Taxol)FDA LinkGeneric 08/2022 - 06/2003
5	regorafenibIBA 01/2020 - 10/2015
5	Sunitinib (Sutent)FDA Link 04/2014 - 01/2010
4	Formaldehyde (Formol)FDA Link 12/2023 - 10/2011
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
4	Imatinib Mesylate (Gleevec)FDA Link 10/2022 - 01/2009
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2020
4	PlatinumIBA 01/2021 - 11/2010
4	Carcinoembryonic AntigenIBA 04/2020 - 12/2017
4	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 01/2011
4	Tyrosine Kinase InhibitorsIBA 01/2016 - 01/2011
3	Cell-Free Nucleic AcidsIBA 12/2023 - 11/2015
3	Indicators and Reagents (Reagents)IBA 12/2023 - 01/2018
3	Pemetrexed (MTA)FDA Link 09/2023 - 01/2018
3	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2023 - 01/2020
3	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2020
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2020 - 01/2014
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 04/2007
3	Small Interfering RNA (siRNA)IBA 01/2018 - 12/2011
3	Alkaline PhosphataseIBA 01/2018 - 01/2007
3	EnzymesIBA 01/2018 - 01/2013
3	Messenger RNA (mRNA)IBA 01/2017 - 01/2004
3	SurvivinIBA 09/2016 - 08/2009
3	pazopanib FDA Link 06/2016 - 11/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 08/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2009 - 11/2004

Therapy/Procedure

85	Drug Therapy (Chemotherapy) 01/2024 - 12/2002
58	Therapeutics 01/2024 - 10/2003
47	Gastrectomy 12/2023 - 01/2010
23	Chemoradiotherapy 01/2023 - 08/2004
17	Combination Drug Therapy (Combination Chemotherapy) 04/2015 - 12/2002
16	Radiotherapy 04/2022 - 09/2007
12	Bariatric Surgery 01/2023 - 10/2017
11	Neoadjuvant Therapy 08/2021 - 01/2007
11	Adjuvant Chemotherapy 11/2019 - 01/2007
7	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2023 - 10/2017
6	Salvage Therapy 09/2023 - 12/2011
6	Precision Medicine 08/2023 - 06/2011
5	Length of Stay 10/2023 - 10/2018
4	Immunotherapy 01/2021 - 09/2017
4	Adjuvant Chemoradiotherapy 12/2018 - 12/2005
4	Lymph Node Excision (Lymph Node Dissection) 06/2017 - 01/2012
3	Metastasectomy 04/2021 - 09/2010